An FDA notice for the Oxbryta recall published on September 26, 2024, revealed that Pfizer Inc., the manufacturer of Oxbryta, voluntarily withdrew the medication from the market, “ceasing distribution, and discontinuing all active clinical trials and expanded access programs for Oxbryta.” What is Oxbryta, exactly, and why did the manufacturer...
Read More